Percutaneous Transluminal Angioplasty (PTA)
CMS has reviewed the evidence and determined that Medicare coverage
of PTA of the renal arteries and PTA concurrent with renal artery stent placement should not be changed.
Therefore, coverage remains as described in section 20.7 and at the discretion of local Medicare contractors,
respectively.
This revision of section 20.7, is a national coverage determination (NCD). NCDs are binding on all carriers,
fiscal intermediaries, quality improvement organizations, qualified independent contractors, the Medicare
appeals council, and administrative law judges (ALJs) (see 42 CFR section 405.1060(a)(4) (2005)). An
NCD that expands coverage is also binding on a Medicare advantage organization. In addition, an ALJ may
not review an NCD. (See section 1869(f)(1)(A)(i) of the Social Security Act.)
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 04, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.